• Guidelines on variations to registered pharmaceutical products
• Guidelines on registration of similar Biotherapeutic products
• Guidelines on registration of Biotherapeutic products
• Guidelines on registration of Human vaccines
• Guidelines on variation of registered Biotherapeutic products
• Submission of documentation for registration of a pharmaceutical product for human use
• Licensing Guidelines 2020 – Gazetted
• Guidelines on Registration of Imported Herbal medicinal products for Human or Veterinary use
• Guidelines on hand sanitizers for use during the COVID-19 pandemic
• Part 1 GMP Guidelines for Medicinal Products_R3
• Part II GMP Guidelines for Medicinal Products (Basic Requirements for APIs)
• Annexes to GMP Guidelines for Medicinal Products_R2
• Guidelines on detecting & reporting adverse drug reactions in Uganda
• NDA insurance cover Guidelines
• NDA Guidelines on registration of Vaccines
• Guidelines for detecting and reporting ADR
• Guidelines for Variation of Registered Vaccines
• Guidelines for the conduct of clinical trials in Uganda
• Guidelines on Good Clinical Practice in the conduct of Clinical Trials involving human participants
• Guidelines for Renewal of Registration of a Pharmaceutical product
• Guidelines for Adverse Events Following Immunization (AEFI)
• Guidelines for registration of Biotherapeutic products
• Guidelines of registration of Similar Biotherapeutic Products
• Guidelines on Periodic Safety Update Reports_R0
• Guidelines on Good Distribution Practice for Pharmaceutical Products
• Guidelines for introducing a new formulation pharmaceutical product on the Uganda market
• Guidelines for recall of a medical product